Skip to main content

Publisher: Elsevier

Volume 26, Number 3, April 2002

Early drop-outs, late drop-outs and completers - Differences in the continuation phase of a clinical trial
pp. 415-419(5)
Authors: Sonawalla, S.B.; Farabaugh, A.H.; Leslie, V.M.; Pava, J.A.; Matthews, J.D.; Fava, M.

Favourites:
ADD

Diversity of glutamate dehydrogenase in human brain
pp. 427-435(9)
Authors: Burbaeva, G.S.; Turishcheva, M.S.; Vorobyeva, E.A.; Savushkina, O.K.; Tereshkina, E.B.; Boksha, I.S.

Favourites:
ADD

5-HT3 receptor ligands lack discriminative stimulus properties
pp. 463-471(9)
Authors: Olivier, B.; Broersen, L.M.; Slangen, J.L.

Favourites:
ADD

Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients - Influence of patient-related variables
pp. 473-480(8)
Authors: Palego, L.; Biondi, L.; Giannaccini, G.; Sarno, N.; Elmi, S.; Ciapparelli, A.; Cassano, G.B.; Lucacchini, A.; Martini, C.; Dell'Osso, L.

Favourites:
ADD

Behavioral effects of MK-801 on reserpine-treated mice
pp. 487-495(9)
Authors: Dutra, R.C.; Andreazza, A.P.; Andreatini, R.; Tufik, S.; Vital, M.A.B.F.

Favourites:
ADD

Delayed onset of inhibition of return in schizophrenia
pp. 505-512(8)
Authors: Larrison-Faucher, A.; Briand, K.A.; Sereno, A.B.

Favourites:
ADD

Distribution of parkin in the adult rat brain
pp. 519-527(9)
Authors: D'Agata, V.; Zhao, W.; Pascale, A.; Zohar, O.; Scapagnini, G.; Cavallaro, S.

Favourites:
ADD

Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
pp. 539-545(7)
Authors: Poyares, D.R.; Guilleminault, C.; Ohayon, M.M.; Tufik, S.

Favourites:
ADD

The use of drug monotherapy in psychiatric inpatient treatment
pp. 547-551(5)
Author: Rittmannsberger, H.

Favourites:
ADD
Favourites:
ADD

Effects of short- and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder
pp. 561-565(5)
Authors: Turan, T.; Esel, E.; Tokgoz, B.; Aslan, S.; Sofuoglu, S.; Utas, C.; Kelestimur, F.

Favourites:
ADD

Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients
pp. 579-584(6)
Authors: Yazici, K.; Yazici, A.E.; Taneli, B.

Favourites:
ADD

Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression
pp. 585-589(5)
Authors: Hornig-Rohan, M.; Amsterdam, J.D.

Favourites:
ADD

Clinical outcome and tolerability of sertraline in major depression - A study with plasma levels
pp. 597-601(5)
Authors: Mauri, M.C.; Laini, V.; Cerveri, G.; Scalvini, M.E.; Volonteri, L.S.; Regispani, F.; Malvini, L.; Manfre, S.; Boscati, L.; Panza, G.

Favourites:
ADD

Agranulocytosis during clozapine therapy
pp. 603-607(5)
Authors: Gaszner, P.; Makkos, Z.; Kosza, P.

Favourites:
ADD
Favourites:
ADD

The brain decade in debate: V-Neurobiology of depression
pp. 613-617(5)
Authors: Barros, H.M.T.; Calil, H.M.; Guimaraes, F.S.; Soares, J.C.; Andreatini, R.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more